Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma is a type of cancer that starts in the upper part of the throat behind the nose, called the nasopharynx. This area is part of the respiratory system and plays a role in breathing and voice production. The cancer can cause symptoms like a persistent nasal blockage, nosebleeds, or hearing problems due to its location near important structures. It often affects the lymph nodes in the neck, leading to noticeable swelling. The disease is linked to infection with the Epstein-Barr virus and certain environmental factors. Early detection is important because the tumor can grow and spread to nearby tissues or distant organs, impacting overall health.

Nasopharyngeal Carcinoma (NPC) is a malignant epithelial tumor arising from the mucosal lining of the nasopharynx, predominantly the fossa of Rosenmüller. It is strongly associated with latent infection by Epstein-Barr virus (EBV), which contributes to oncogenesis through viral oncogenes and immune evasion. NPC is characterized by its unique epidemiology, with higher incidence in Southeast Asia and North Africa. The tumor often presents as a poorly differentiated or undifferentiated carcinoma with a high propensity for early regional lymph node metastasis. Clinical significance lies in its aggressive local invasion and potential for distant metastases, especially to bone, lung, and liver. Diagnosis and staging rely on imaging and histopathology, with EBV DNA levels serving as a useful biomarker. Treatment typically involves radiotherapy combined with chemotherapy due to the tumor’s radiosensitivity.